Cargando…
A rare case of bifocal, extramedullary and hyposecretory relapse of multiple myeloma
We present a rare extramedullary, bifocal, and hyposecretory manifestation of relapsed MM that could be mistaken for an infection. We stress the importance of complex evaluation including serum, urine, and bone marrow assessment and whole‐body imaging.
Autores principales: | Minarik, Jiri, Szotkowski, Tomas, Hrbek, Jan, Krhovska, Petra, Buriankova, Eva, Proskova, Jitka, Pika, Tomas, Bacovsky, Jaroslav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346602/ https://www.ncbi.nlm.nih.gov/pubmed/34401156 http://dx.doi.org/10.1002/ccr3.4570 |
Ejemplares similares
-
Whole-genome optical mapping of bone-marrow myeloma cells reveals association of extramedullary multiple myeloma with chromosome 1 abnormalities
por: Kriegova, Eva, et al.
Publicado: (2021) -
Prognostic Value of Hepatocyte Growth Factor, Syndecan-1, and Osteopontin in Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance
por: Minarik, Jiri, et al.
Publicado: (2012) -
Ixazomib, Lenalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma in Routine Clinical Practice: Extended Follow-Up Analysis and the Results of Subsequent Therapy
por: Minarik, Jiri, et al.
Publicado: (2022) -
Identification of patients at high risk of secondary extramedullary multiple myeloma development
por: Stork, Martin, et al.
Publicado: (2021) -
Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice
por: Minarik, Jiri, et al.
Publicado: (2021)